Virus-like Particle Vaccines and Platforms for Vaccine Development

Virus-like particles (VLPs) have gained a lot of interest within the past two decades. The use of VLP-based vaccines to protect against three infectious agents—hepatitis B virus, human papillomavirus, and hepatitis E virus—has been approved; they are very efficacious and offer long-lasting immune re...

Descripción completa

Detalles Bibliográficos
Autores principales: Kheirvari, Milad, Liu, Hong, Tumban, Ebenezer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223759/
https://www.ncbi.nlm.nih.gov/pubmed/37243195
http://dx.doi.org/10.3390/v15051109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223759/
https://www.ncbi.nlm.nih.gov/pubmed/37243195
http://dx.doi.org/10.3390/v15051109

Ejemplares similares